PreveCeutical Medical (FRA:18H0) Cyclically Adjusted Book per Share: €0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PreveCeutical Medical Cyclically Adjusted Book per Share?

PreveCeutical Medical FRA:18H0 Cyclically Adjusted Book per Share is €0.00 as of Dec. 2025. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PreveCeutical Medical's adjusted book value per share for the three months ended in Dec. 2025 was €-0.006. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Dec. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-14), PreveCeutical Medical's current stock price is €0.008. PreveCeutical Medical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was €0.00. PreveCeutical Medical's Cyclically Adjusted PB Ratio of today is .


PreveCeutical Medical  (FRA:18H0) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PreveCeutical Medical Cyclically Adjusted Book per Share Related Terms


PreveCeutical Medical Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for PreveCeutical Medical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PreveCeutical Medical Cyclically Adjusted Book per Share Chart

PreveCeutical Medical Annual Data
Trend Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PreveCeutical Medical Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.01 0.00 0.00

FRA:18H0 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, PreveCeutical Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PreveCeutical Medical Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PreveCeutical Medical's Cyclically Adjusted PB Ratio falls into.



PreveCeutical Medical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PreveCeutical Medical's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.006/130.3661*130.3661
=-0.006

Current CPI (Dec. 2025) = 130.3661.

PreveCeutical Medical Quarterly Data

Book Value per Share CPI Adj_Book
201601 0.000 100.184 0.000
201604 0.000 101.370 0.000
201607 0.001 101.844 0.001
201610 0.000 102.002 0.000
201701 0.002 102.318 0.003
201704 0.002 103.029 0.003
201709 -0.001 103.345 -0.001
201712 -0.001 103.345 -0.001
201803 -0.004 105.004 -0.005
201806 0.006 105.557 0.007
201809 0.002 105.636 0.002
201812 -0.004 105.399 -0.005
201903 -0.005 106.979 -0.006
201906 -0.007 107.690 -0.008
201909 -0.009 107.611 -0.011
201912 -0.008 107.769 -0.010
202003 -0.008 107.927 -0.010
202006 -0.005 108.401 -0.006
202009 -0.004 108.164 -0.005
202012 -0.005 108.559 -0.006
202103 -0.004 110.298 -0.005
202106 -0.005 111.720 -0.006
202109 -0.005 112.905 -0.006
202112 -0.006 113.774 -0.007
202203 -0.006 117.646 -0.007
202206 -0.006 120.806 -0.006
202209 -0.007 120.648 -0.008
202212 -0.006 120.964 -0.006
202303 -0.006 122.702 -0.006
202306 -0.007 124.203 -0.007
202309 -0.007 125.230 -0.007
202312 -0.007 125.072 -0.007
202403 -0.008 126.258 -0.008
202406 -0.008 127.522 -0.008
202409 -0.008 127.285 -0.008
202412 -0.008 127.364 -0.008
202503 -0.009 129.181 -0.009
202506 -0.008 129.892 -0.008
202509 -0.008 130.287 -0.008
202512 -0.006 130.366 -0.006

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.00 mean?
PreveCeutical Medical (FRA:18H0) has a Cyclically Adjusted Book per Share of €0.00 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PreveCeutical Medical and its competitors.
Is PreveCeutical Medical's Cyclically Adjusted Book per Share too high?
PreveCeutical Medical's current Cyclically Adjusted Book per Share is €0.00.
How does PreveCeutical Medical's Cyclically Adjusted Book per Share compare to VRTX and REGN?
PreveCeutical Medical's Cyclically Adjusted Book per Share of €0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PreveCeutical Medical and its competitors. PreveCeutical Medical's current Cyclically Adjusted Book per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PreveCeutical Medical stock overvalued right now?
PreveCeutical Medical (FRA:18H0) has a current Cyclically Adjusted Book per Share of €0.00. The current Cyclically Adjusted Book per Share is €0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For PreveCeutical Medical (FRA:18H0), the current Cyclically Adjusted Book per Share is €0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PreveCeutical Medical Business Description

Other Exchanges PRVCF:USAPREV:Canada
Address 550 Burrard Street, Bentall 5, Suite 2501, Vancouver, BC, CAN, V6C 2B5
PreveCeutical Medical Inc is a health sciences company. The principal business activity of the company is the development of options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.